Get started
Work

Prediction of PARP inhibitor response and resistance utilizing a CTC phenotypic classifer in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from the NCI 9012 trial

Year: 2016
Type: article
DOI: 10.1093/annonc/mdw372.14
Authors: F.Y. Feng, S. Daignault-Newton, A. Jendrisak, Y. Wang, S. Greene, A. Rodriguez, J. Lee, L. Dugan, J. Siddiqui, J. Louw, C. Johnson, P. Twardowski, C. Albany, M. Stein, W.M. Stadler, L. Kunju, A.M. Chinnaiyan, M. Landers, R. Dittamore, M. Hussain
Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of Michigan, Epic Sciences (United States), Michigan Center for Translational Pathology, City Of Hope National Medical Center, City of Hope, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Rutgers Cancer Institute, University of Chicago, University of Chicago Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2588304658
FWCI:
Cites:
Cited by:
Related to: 10